1. Home
  2. PRTA vs SAFE Comparison

PRTA vs SAFE Comparison

Compare PRTA & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • SAFE
  • Stock Information
  • Founded
  • PRTA 2012
  • SAFE 2016
  • Country
  • PRTA Ireland
  • SAFE United States
  • Employees
  • PRTA N/A
  • SAFE N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • SAFE Real Estate Investment Trusts
  • Sector
  • PRTA Health Care
  • SAFE Real Estate
  • Exchange
  • PRTA Nasdaq
  • SAFE Nasdaq
  • Market Cap
  • PRTA 1.2B
  • SAFE 1.3B
  • IPO Year
  • PRTA N/A
  • SAFE 2017
  • Fundamental
  • Price
  • PRTA $21.89
  • SAFE $26.88
  • Analyst Decision
  • PRTA Buy
  • SAFE Buy
  • Analyst Count
  • PRTA 7
  • SAFE 9
  • Target Price
  • PRTA $58.83
  • SAFE $28.22
  • AVG Volume (30 Days)
  • PRTA 255.3K
  • SAFE 307.4K
  • Earning Date
  • PRTA 10-31-2024
  • SAFE 10-29-2024
  • Dividend Yield
  • PRTA N/A
  • SAFE 2.66%
  • EPS Growth
  • PRTA N/A
  • SAFE N/A
  • EPS
  • PRTA N/A
  • SAFE N/A
  • Revenue
  • PRTA $217,246,000.00
  • SAFE $400,237,000.00
  • Revenue This Year
  • PRTA $59.66
  • SAFE N/A
  • Revenue Next Year
  • PRTA N/A
  • SAFE $6.40
  • P/E Ratio
  • PRTA N/A
  • SAFE N/A
  • Revenue Growth
  • PRTA 276.98
  • SAFE 24.05
  • 52 Week Low
  • PRTA $18.69
  • SAFE $15.00
  • 52 Week High
  • PRTA $55.89
  • SAFE $26.62
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.55
  • SAFE 73.01
  • Support Level
  • PRTA $20.15
  • SAFE $24.16
  • Resistance Level
  • PRTA $22.83
  • SAFE $25.51
  • Average True Range (ATR)
  • PRTA 0.82
  • SAFE 0.59
  • MACD
  • PRTA 0.13
  • SAFE 0.08
  • Stochastic Oscillator
  • PRTA 82.66
  • SAFE 90.81

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About SAFE Safehold Inc. New

Safehold Inc is a REIT that operates its business by acquiring, managing and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that is net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.

Share on Social Networks: